Study Group: VNS Users for Epilepsy(?)
Council Members in this Study Group: 28
Request a survey with this Study Group
Leading Experts in this Study Group
Daniel Wynn, MD
Director, Clinical Research
Consultants In Neurology Ltd.
Daniel Wynn, MD, FACN, FAASM, is a Director of Clinical Research at Consultants in Neurology in Chicago, Illinois. He has expertise in a wide variety of neurological illnesses and has served as a principal investigator in over 100 clinical trials in multiple sclerosis, Alzheimer's disease, stroke, chronic...
Neurologist
Medford Neurological Clinic, Inc.
Walter Carlini, MD, PhD, is a General Neurologist at Medford Neurological Clinic in Oregon. His clinical interests include stroke, epilepsy, migraine, dementia, movement disorders, and multiple sclerosis. Dr. Carlini has expertise in clinical neurophysiology and in the use of botulinum toxin injections...
Chief Executive Officer and Medical Director
Spinal and Neurosurgical Institute
Wayel Kaakaji, MD, is the Chief Executive Officer and Medical Director at the Spinal and Neurosurgical Institute. He has expertise in the management of brain and spine tumors and movement disorder surgery such as deep brain stimulation for Parkinson's disease. Dr. Kaakaji has interest in surgical pain...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Medtronic might see a significant drop in its sales as a result of closer scrutiny of off-label use of its products. Infuse has been a cash cow for Medtronic, and if sales drop, it will reflect deeply in the sales numbers.
Prostate cancer can be treated by Cyberknife, and the numbers of patients treated and the number of units sold by Accuray (ARAY:NASDAQ) will very likely increase dramatically over the next 5-10 years.
Abuse resistant long acting narcotics offer benefit as they are less desirable to those who might wish a quick high via snorting, injecting crushed time-release narcotic. Unfortunately, given the higher cost than long acting generics and increased pressure on physicians to prescribe generics, expect...
FDA has approved lacosamide for add-on therapy of partial onset seizures. It will be marketed by UCB under the brand name Vimpat.
The data presented by multiple professional societies does not lend clinical support of many Medtronic products in the Medicare population. The data does not support the use of disc arthroplasty in the Medicare population, and does not find any clinical advantage of kyphoplasty over vertebroplasty. ...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
- Academic Institution*
- Consultancy, Pharma-Focused
- Pharmaceuticals Manufacturer
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Physician - Division Head
- President
- Physician - Department Chair
- Owner
- Chief Executive Officer
- Assistant Professor
- Director
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms